BACKGROUND AND PURPOSE: Previous studies have suggested that structural changes do occur in the brain of patients with schizophrenia compared with healthy control participants. However, findings from such studies are inconclusive, probably because of the different methodologic approaches, the clinical heterogeneity of patient samples, and also the fact that patients enrolled were treated with antipsychotic drugs. The aim of this study was to investigate brain GM volumes and intrinsic structural WM changes in first-contact, antipsychotic drug-naïve patients with schizophrenia. MATERIALS AND METHODS: A total of 43 first-contact, drug-naïve, patients with schizophrenia and 17 age-matched control participants were studied. All participants underwent T1-weighted MR imaging and DTI scans. Voxel-based morphometry and tract-based spatial statistics were used to compare GM volumes and WM DTI metrics between groups. MR imaging measures were correlated with the duration of the untreated psychosis and the clinical positive and negative symptoms. RESULTS: Compared with control participants, patients with schizophrenia showed smaller volumes of the temporal, parietal, and occipital GM, and a pattern of decreased mean diffusivity and increased fractional anisotropy in the brain stem and cerebellum bilaterally, interhemispheric and cortico-cortical connections bilaterally, and right anterior and posterior limb of the internal capsule. In patients, decreased mean diffusivity and increased fractional anisotropy in several brain regions were related to a longer duration of the untreated psychosis and the severity of positive symptoms. CONCLUSIONS: First-contact, drug-naïve, patients with schizophrenia present with volumetric and DTI changes, which correlated with their clinical features. This study increases our knowledge on the neural networks involved in the pathophysiologic mechanisms of schizophrenia.
BACKGROUND AND PURPOSE: Previous studies have suggested that structural changes do occur in the brain of patients with schizophrenia compared with healthy control participants. However, findings from such studies are inconclusive, probably because of the different methodologic approaches, the clinical heterogeneity of patient samples, and also the fact that patients enrolled were treated with antipsychotic drugs. The aim of this study was to investigate brain GM volumes and intrinsic structural WM changes in first-contact, antipsychotic drug-naïve patients with schizophrenia. MATERIALS AND METHODS: A total of 43 first-contact, drug-naïve, patients with schizophrenia and 17 age-matched control participants were studied. All participants underwent T1-weighted MR imaging and DTI scans. Voxel-based morphometry and tract-based spatial statistics were used to compare GM volumes and WM DTI metrics between groups. MR imaging measures were correlated with the duration of the untreated psychosis and the clinical positive and negative symptoms. RESULTS: Compared with control participants, patients with schizophrenia showed smaller volumes of the temporal, parietal, and occipital GM, and a pattern of decreased mean diffusivity and increased fractional anisotropy in the brain stem and cerebellum bilaterally, interhemispheric and cortico-cortical connections bilaterally, and right anterior and posterior limb of the internal capsule. In patients, decreased mean diffusivity and increased fractional anisotropy in several brain regions were related to a longer duration of the untreated psychosis and the severity of positive symptoms. CONCLUSIONS: First-contact, drug-naïve, patients with schizophrenia present with volumetric and DTI changes, which correlated with their clinical features. This study increases our knowledge on the neural networks involved in the pathophysiologic mechanisms of schizophrenia.
Authors: Philipp A Thomann; Martin Roebel; Vasco Dos Santos; Silke Bachmann; Marco Essig; Johannes Schröder Journal: Psychiatry Res Date: 2009-06-21 Impact factor: 3.222
Authors: V Cheung; C P Y Chiu; C W Law; C Cheung; C L M Hui; K K S Chan; P C Sham; M Y Deng; K S Tai; P-L Khong; G M McAlonan; S-E Chua; E Chen Journal: Psychol Med Date: 2011-08 Impact factor: 7.723
Authors: Sukhwinder S Shergill; Michael J Brammer; Rimmei Fukuda; Steven C R Williams; Robin M Murray; Philip K McGuire Journal: Br J Psychiatry Date: 2003-06 Impact factor: 9.319
Authors: V Cheung; C Cheung; G M McAlonan; Y Deng; J G Wong; L Yip; K S Tai; P L Khong; P Sham; S E Chua Journal: Psychol Med Date: 2007-10-22 Impact factor: 7.723
Authors: Michael D De Bellis; Elizabeth Van Voorhees; Stephen R Hooper; Nicole Gibler; Lauren Nelson; Steve G Hege; Martha E Payne; James MacFall Journal: Alcohol Clin Exp Res Date: 2008-01-30 Impact factor: 3.455
Authors: S Lui; L Yao; Y Xiao; S K Keedy; J L Reilly; R S Keefe; C A Tamminga; M S Keshavan; G D Pearlson; Q Gong; J A Sweeney Journal: Psychol Med Date: 2014-05-20 Impact factor: 7.723
Authors: Patricia Alvarado-Alanis; Pablo León-Ortiz; Francisco Reyes-Madrigal; Rafael Favila; Oscar Rodríguez-Mayoral; Humberto Nicolini; Mariana Azcárraga; Ariel Graff-Guerrero; Laura M Rowland; Camilo de la Fuente-Sandoval Journal: Schizophr Res Date: 2015-01-22 Impact factor: 4.939
Authors: Li Yao; Su Lui; Wei Deng; Min Wu; Lizhou Chen; Yuan Xiao; Sunima Lama; Wenjing Zhang; Xiaoqi Huang; Tao Li; Qiyong Gong Journal: MAGMA Date: 2013-10-08 Impact factor: 2.310
Authors: Peter C T Hawkins; Tobias C Wood; Anthony C Vernon; Alessandro Bertolino; Fabio Sambataro; Juergen Dukart; Emilio Merlo-Pich; Celine Risterucci; Hanna Silber-Baumann; Eamonn Walsh; Ndabezinhle Mazibuko; Fernando O Zelaya; Mitul A Mehta Journal: Hum Brain Mapp Date: 2017-10-23 Impact factor: 5.038
Authors: Johanna Seitz; Jessica X Zuo; Amanda E Lyall; Nikos Makris; Zora Kikinis; Sylvain Bouix; Ofer Pasternak; Eli Fredman; Jonathan Duskin; Jill M Goldstein; Tracey L Petryshen; Raquelle I Mesholam-Gately; Joanne Wojcik; Robert W McCarley; Larry J Seidman; Martha E Shenton; Inga K Koerte; Marek Kubicki Journal: Schizophr Bull Date: 2016-03-23 Impact factor: 9.306
Authors: Jayachandra M Raghava; René C W Mandl; Mette Ø Nielsen; Birgitte Fagerlund; Birte Y Glenthøj; Egill Rostrup; Bjørn H Ebdrup Journal: Brain Imaging Behav Date: 2021-02 Impact factor: 3.978
Authors: Nina Vanessa Kraguljac; Thomas Anthony; Frank Michael Skidmore; Jon Marstrander; Charity Johanna Morgan; Meredith Amanda Reid; David Matthew White; Ripu Daman Jindal; Nicholas Harry Melas Skefos; Adrienne Carol Lahti Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2019-01-23